Muir Kevin 4
4 · DELCATH SYSTEMS, INC. · Filed Feb 18, 2026
Research Summary
AI-generated summary of this filing
Delcath Systems (DCTH) GM Kevin Muir Receives Equity Award
What Happened
Kevin Muir, General Manager, Interventional Oncology at Delcath Systems, received equity awards on February 17, 2026: a derivative option award for 56,500 shares (recorded at $0.00) and 28,250 restricted stock units (RSUs) (recorded at $0.00). Total awards = 84,750 units. These were grants/awards (not open-market purchases or sales), so they represent compensation equity rather than an investment transaction with cash changing hands at the time of grant.
Key Details
- Transaction date: February 17, 2026; Form 4 filed February 18, 2026 (timely filing).
- Awards: 56,500 derivative (option) units @ $0.00; 28,250 RSUs @ $0.00; total 84,750.
- Shares owned after transaction: Not disclosed in the provided filing excerpt.
- Footnotes:
- F1: Option vests 1/36th per month starting Feb 17, 2026, subject to continued employment and plan terms.
- F2: Each RSU converts to one share of common stock upon settlement.
- F3: RSU vesting schedule — one-third vests Feb 17, 2027; the remaining two-thirds vest in equal annual installments over the next two years, subject to continued service.
- No immediate sale or exercise reported; no cash proceeds shown.
Context
These are compensation grants: options require vesting (and later exercise) to become shares, while RSUs convert to shares when they vest/settle. Because the filing records awards (A) and not purchases or sales, this is not a market-direction trade signal but rather management/employee compensation that will dilute when shares are issued/settled. Check company disclosures (proxy, equity plan) for exercise price and potential dilution details.
Insider Transaction Report
- Award
Stock Option (Right to Buy)
[F1]2026-02-17+56,500→ 56,500 totalExercise: $9.40Exp: 2036-02-17→ Common Stock (56,500 underlying) - Award
Restricted Stock Units
[F2][F3]2026-02-17+28,250→ 28,250 total→ Common Stock (28,250 underlying)
Footnotes (3)
- [F1]The option will vest and become exercisable at the rate of one-thirty-sixth (1/36th) per month with the first such vesting to occur on February 17, 2026 and monthly thereafter for so long as the reporting person remains an employee of Delcath Systems, Inc. (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended).
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.
- [F3]Represents an RSU award, one-third of which shall vest on February 17, 2027 with the remaining 2/3 two-thirds of the RSUs vesting in equal annual installments over the following two years. The vesting of the RSUs is subject to the Reporting Person's continuous service through each such vesting date.